SEK 13.95
(1.09%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 13.13 Million EUR | -30.68% |
2022 | 18.94 Million EUR | 421.9% |
2021 | 3.62 Million EUR | -46.33% |
2020 | 6.76 Million EUR | 751.08% |
2019 | 794.63 Thousand EUR | -4.51% |
2018 | 832.13 Thousand EUR | 56.06% |
2017 | 533.22 Thousand EUR | 3.49% |
2016 | 515.26 Thousand EUR | 763.73% |
2015 | 59.65 Thousand EUR | -67.53% |
2014 | 183.73 Thousand EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 13.25 Million EUR | 3.57% |
2024 Q1 | 12.79 Million EUR | -2.53% |
2023 Q3 | 18.89 Million EUR | 6.03% |
2023 FY | 13.13 Million EUR | -30.68% |
2023 Q1 | 19.13 Million EUR | 1.03% |
2023 Q4 | 13.13 Million EUR | -30.51% |
2023 Q2 | 17.82 Million EUR | -6.88% |
2022 Q3 | 20.02 Million EUR | -9.07% |
2022 Q1 | 15.94 Million EUR | 339.19% |
2022 FY | 18.94 Million EUR | 421.9% |
2022 Q4 | 18.94 Million EUR | -5.4% |
2022 Q2 | 22.02 Million EUR | 38.14% |
2021 Q1 | 6.86 Million EUR | 1.53% |
2021 FY | 3.62 Million EUR | -46.33% |
2021 Q3 | 4.37 Million EUR | -37.14% |
2021 Q4 | 3.62 Million EUR | -17.1% |
2021 Q2 | 6.96 Million EUR | 1.44% |
2020 Q1 | - EUR | 0.0% |
2020 FY | 6.76 Million EUR | 751.08% |
2020 Q4 | 6.76 Million EUR | 0.0% |
2019 FY | 794.63 Thousand EUR | -4.51% |
2018 FY | 832.13 Thousand EUR | 56.06% |
2017 FY | 533.22 Thousand EUR | 3.49% |
2016 FY | 515.26 Thousand EUR | 763.73% |
2015 FY | 59.65 Thousand EUR | -67.53% |
2014 FY | 183.73 Thousand EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aino Health AB (publ) | 14.36 Million SEK | 8.587% |
Bonzun AB (publ) | 6.95 Million SEK | -88.942% |
Kontigo Care AB (publ) | 19.05 Million SEK | 31.076% |
Medhelp Care Aktiebolag (publ) | 36.98 Million SEK | 64.496% |
RaySearch Laboratories AB (publ) | 1.21 Billion SEK | 98.921% |
Surgical Science Sweden AB (publ) | 357.46 Million SEK | 96.326% |